References
Morcos SK, Bellin MF, Thomsen HS, Almén T, Aspelin P, Heinz-Peer G, et al. Reducing the risk of iodine-based and MRI contrast media administration: recommendation for a questionnaire at the time of booking. Eur J Radiol 2008;66: 225–229.
Shigenaga A, Suzuki H, Hayama K, Nishioka A, Usuda C. Steps and problems of EBM diagnosis and treatment guideline. Int Med Inform Center (IMIC) 2004;25:17–28 (in Japanese).
Fukui T, Yoshida M, Yamaguchi N, editors. Minds guidance of diagnosis and treatment guideline 2007. Tokyo: Igaku-Shoin; 2007. p. 43 (in Japanese).
Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K. Adverse reactions to ionic and nonionic contrast media: a report from the Japanese Committee on the Safety of Contrast Media. Radiology 1990;175:621–628.
Katayama H, Yamaguchi K, Kozuka T, Takashima T, Matsuura K, Nakata H, et al. Full-scale investigation into adverse reaction in Japan: risk factor analysis the Japanese Committee on the Safety of Contrast Media. Invest Radiol 1991;26: S33–S36.
Mikkonen R, Kontkanen T, Kivisaari L. Acute and late adverse reactions to low-osmolal contrast media. Acta Radiol 1995;36:72–76.
Bettmann MA, Heeren T, Greenfield A, Goudey C. Adverse events with radiographic contrast agents: results of the SCVIR contrast agent registry. Radiology 1997;203:611–620.
Shimura H, Takazawa K, Endo T, Tawada M, Onaya T. A case of T4-thyroid storm that developed after using iodine contrast medium. Clin Endocrinol 1989;37(S):97–100 (in Japanese).
Martin FIR, Deam DR. Hyperthyroidism in elderly hospitalised patients: clinical features and treatment outcomes. Med J Aust 1996;164:200–203.
De Bruin TWA. Iodide-induced hyperthyroidism with computed tomography contrast fluid. Lancet 1994;343:1160–1161.
Abe M, Kimura T, Morimoto T, Furukawa Y, Kita T. Incidence of and risk factors for contrast-induced nephropathy after cardiac catheterization in Japanese patients. Circ J 2009;73:1518–1522.
Dangas G, Iakovou I, Nikolsky E, Aymong ED, Mintz GS, Kipshidze NN, et al. Contrast-Induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 2005;95: 13–19.
Rudnick MR, Goldfarb S, Wexler L, Loudbrook PA, Murphy MJ, Halpern EF, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. Kidney Int 1995;47:254–261.
Bartholomew BA, Harjai KJ, Dukkipati S, Boura JA, Yerkey MW, Glazier S, et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 2004;93:1515–1519.
Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002;105:2259–2264.
Mukherjee JJ, Peppercorn PD, Reznek RH, Patel V, Kaltsas G, Besser M, et al. Pheochromocytoma: effect of nonionic contrast medium in CT on circulating catecholamine levels. Radiology 1997;202:227–231.
Baid SK, Lai EW, Wesley RA, Ling A, Timmers HJLM, Adams KT, et al. Brief communication: radiographic contrast infusion and catecholamine release in patients with pheochromocytoma. Ann Intern Med 2009;150:27–32.
Lasser EC, Lang JH, Zawadzki ZA. Myeloma protein precipitates in urography. JAMA 1966;198:945–947.
Matsumoto J, Yasaka T, Ohya I, Ohtani H. Acute renal failure in primary macroglobulinemia with small-molecule IgM. Arch Intern Med 1985;145:929–931.
Webb JAW, Thomsen HS, Morcos SK, Members of Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR). The use of iodinated and gadolinium contrast media during pregnancy and lactation. Eur Radiol 2005;15:1234–1240.
Atwell TD, Lteif AN, Brown DL, McCann M, Townsend JE, LeRoy AJ. Neonatal Thyroid function after administration of IV iodinated contrast agent to 21 pregnant patients. AJR Am J Roentgenol 2008;191:268–271.
Nielsen ST, Matheson I, Rasmussen JR, Skinnemoen K, Andrew E, Hafsahl G. Excretion of iohexol and metrizoate in human breast milk. Acta Radiol 1987;28:523–526.
Rasuli P, Hammond DI. Metformin and contrast media: where is the conflict? Can Assoc Radiol J 1998;49:161–166.
McCartney MM, Gilbert FJ, Murchison LE, Pearson D, McHardy K, Murray AD. Metformin and contrast media: a dangerous combination? Clin Radiol 1999;54:29–33.
Choyke PL, Miller DL, Lotze MT, Whiteis JM, Ebbitt B, Rosenberg SA. Delayed reactions to contrast media after interleukin-2 immunotherapy. Radiology 1992;183:111–114.
Lang DM, Alpern MB, Visintainer PF, Smith ST. Increased risk for anaphylactoid reaction from contrast media in patients on β-adrenergic blockers or with asthma. Ann Intern Med 1991;115:270–276.
Greenberger PA, Meyers SN, Kramer BL, Kramer BL. Effects of beta-adrenergic and calcium antagonists on the development of anaphylactoid reactions from radiographic contrast media during cardiac angiography. J Allergy Clin Immunol 1987;80:698–702.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Hayashi, H., Narumi, Y., Takagi, R. et al. Questionnaires for examinations using iodinated contrast media and their grades of recommendation: Japan Radiological Society/Japanese College of Radiology Joint Committee on Contrast Media Safety. Jpn J Radiol 29, 744–748 (2011). https://doi.org/10.1007/s11604-011-0616-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11604-011-0616-4